Immuneering Corp
IMRXNasdaqCIK 1790340HealthcareFiscal year ends Dec 31
Reports and events: 78 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:22 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001790340-26-000097 |
| 2026-10-2916:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-26-000095 |
| 2026-08-0507:57 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001790340-26-000091 |
| 2026-08-0507:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-26-000088 |
| 2026-06-1516:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001790340-26-000074 |
| 2026-06-1117:16 ET | 8-K | 5.07 Shareholder vote results | 0001790340-26-000062 |
| 2026-06-0116:51 ET | 8-K | 8.01 Other events | 0001790340-26-000059 |
| 2026-05-1507:52 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001790340-26-000057 |
| 2026-05-1507:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-26-000055 |
| 2026-04-2016:10 ET | DEF 14A | Proxy statementPeriod 2026-04-20 | 0001790340-26-000048 |
| 2026-03-0608:29 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001790340-26-000042 |
| 2026-03-0608:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-26-000040 |
| 2026-01-0716:10 ET | 8-K | 8.01 Other events | 0001790340-26-000006 |
| 2025-11-1216:19 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001790340-25-000135 |
| 2025-11-1216:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-25-000133 |
| 2025-09-2517:23 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-093436 |
| 2025-09-2416:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-092957 |
| 2025-08-2520:58 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-081995 |
| 2025-08-1316:25 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001790340-25-000104 |
| 2025-08-1316:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-25-000102 |
| 2025-06-1706:09 ET | 8-K | 8.01 Other events | 0001790340-25-000077 |
| 2025-06-1608:44 ET | 8-K | 5.07 Shareholder vote results | 0001790340-25-000063 |
| 2025-05-0516:34 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001790340-25-000061 |
| 2025-05-0516:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-25-000059 |
| 2025-04-2116:50 ET | DEF 14A | Proxy statementPeriod 2025-04-21 | 0001790340-25-000053 |
| 2025-03-2016:47 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001790340-25-000042 |
| 2025-03-2016:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-25-000039 |
| 2025-01-1316:36 ET | 8-K | 8.01 Other events | 0001790340-25-000014 |
| 2025-01-0708:26 ET | 8-K | 8.01 Other events | 0001790340-25-000012 |
| 2024-11-1316:09 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001790340-24-000080 |
| 2024-11-1316:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-24-000078 |
| 2024-10-0216:11 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001790340-24-000073 |
| 2024-09-1216:11 ET | 8-K | 8.01 Other events | 0001790340-24-000069 |
| 2024-08-0616:12 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001790340-24-000066 |
| 2024-08-0616:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-24-000064 |
| 2024-06-1316:09 ET | 8-K | 5.07 Shareholder vote results | 0001790340-24-000060 |
| 2024-05-2316:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001790340-24-000058 |
| 2024-05-0716:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001790340-24-000056 |
| 2024-05-0716:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-24-000054 |
| 2024-04-2316:12 ET | DEF 14A | Proxy statementPeriod 2024-04-23 | 0001790340-24-000044 |
| 2024-03-1407:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-24-034204 |
| 2024-03-0108:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001790340-24-000024 |
| 2024-03-0107:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-24-000022 |
| 2024-02-0216:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-010041 |
| 2023-11-0916:12 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001790340-23-000056 |
| 2023-11-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-23-000054 |
| 2023-08-0316:10 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001790340-23-000048 |
| 2023-08-0316:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-23-000046 |
| 2023-06-1516:15 ET | 8-K | 5.07 Shareholder vote results | 0001790340-23-000029 |
| 2023-06-1416:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001790340-23-000025 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:24 ET. Listed shows no prices and gives no investment advice.